Ertugliflozin: Phase III data
Top-line data from the double-blind, international Phase III VERTIS SITA2 trial in 463 Type II diabetics inadequately controlled on Januvia sitagliptin and metformin showed that once-daily 5 and 15 mg oral ertugliflozin plus Januvia and metformin
